Article in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
13 authors.
Jéssica Celerino Dos SantosMolecular Biology Laboratory, University of Pernambuco (UPE), Multicampi Garanhuns, Garanhuns 55294-902, PE, Brazil.ORCID 0000-0002-1692-1360
Josival Emanuel Ferreira AlvesKeizo Asami Immunopathology Laboratory (LIKA), Federal University of Pernambuco, Recife 50670-901, PE, Brazil.
Rafael David Souto de AzevedoMolecular Biology Laboratory, University of Pernambuco (UPE), Multicampi Garanhuns, Garanhuns 55294-902, PE, Brazil.ORCID 0000-0002-1310-7662
Josefa Gerlane da SilvaMolecular Biology Laboratory, University of Pernambuco (UPE), Multicampi Garanhuns, Garanhuns 55294-902, PE, Brazil.
Maria Regina de Oliveira SilvaMolecular Biology Laboratory, University of Pernambuco (UPE), Multicampi Garanhuns, Garanhuns 55294-902, PE, Brazil.
Lucia Patrícia Bezerra Gomes da SilvaMolecular Biology Laboratory, University of Pernambuco (UPE), Multicampi Garanhuns, Garanhuns 55294-902, PE, Brazil.
Caio Victor Silva SoaresInstitute of Health Sciences, University of International Integration of Afro-Brazilian Lusophony (UNILAB), Redenção 62790-970, CE, Brazil.ORCID 0009-0000-1184-6405
Jamire Muriel da SilvaChemistry and Therapeutic Innovation Laboratory (LQIT), Department of Antibiotics, Federal University of Pernambuco, Recife 50670-901, PE, Brazil.ORCID 0000-0001-9461-2478
Nabuêr Francieli da SilvaMolecular Biology Laboratory, University of Pernambuco (UPE), Multicampi Garanhuns, Garanhuns 55294-902, PE, Brazil.ORCID 0000-0002-9248-465X
Jamerson Ferreira de OliveiraInstitute of Health Sciences, University of International Integration of Afro-Brazilian Lusophony (UNILAB), Redenção 62790-970, CE, Brazil.ORCID 0000-0001-9606-8154
Maria do Carmo Alves de LimaChemistry and Therapeutic Innovation Laboratory (LQIT), Department of Antibiotics, Federal University of Pernambuco, Recife 50670-901, PE, Brazil.ORCID 0000-0002-8277-3458
Ricardo Olímpio de MouraDepartment of Pharmacy, Laboratory of Synthesis and Vectorization of Molecules, State University of Paraíba (UEPB), Campina Grande 58429-500, PB, Brazil.ORCID 0000-0002-1590-3750
Sinara Mônica Vitalino de AlmeidaMolecular Biology Laboratory, University of Pernambuco (UPE), Multicampi Garanhuns, Garanhuns 55294-902, PE, Brazil.ORCID 0000-0002-2605-4192
Funding
Fundação de Amparo à Ciência e Tecnologia de Pernambuco APQ-1001-4.03/24Fundação de Amparo à Ciência e Tecnologia de Pernambuco APQ-1508-4.03/24Fundação de Amparo à Ciência e Tecnologia de Pernambuco APQ-1581-4.03/25National Council for Scientific and Technological Development DCR-0010-4.03/20
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Biological and Teratogenic Evaluations of Nitrogen Heterocycles for Anticancer Therapy. · full record | OpenQuestion